Evidence map›Paper›PMID 30796683›Full record

ArticleBulletin of mathematical biology2019

Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue.

Susan Christine Massey, Andrea Hawkins-Daarud, Jill Gallaher, Alexander R A Anderson, Peter Canoll, Kristin R Swanson

Open access · greenAbstract read
In one paragraph

Article in Bulletin of mathematical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Susan Christine MasseyPrecision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA. massey.susan@mayo.edu.ORCID 0000-0002-4680-7796
Andrea Hawkins-DaarudPrecision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA.
Jill GallaherIntegrative Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Alexander R A AndersonIntegrative Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Peter CanollDivision of Neuropathology, Department of Pathology and Cell Biology, Columbia University School of Medicine, New York, NY, USA.
Kristin R SwansonPrecision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA.
WinnMed · USMoffitt Cancer Center · USColumbia University · US

Funding

RadiochemistryP01CA042045 · NCI · UNIVERSITY OF WASHINGTON · PI LINK, JEANNE MEYERS · 1986 to 2015
$23.2M
"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"U54CA193489 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, GATENBY, ROBERT A · 2015 to 2020
$12.5M
Trans Network ProjectU54CA210180 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WHITE, FOREST M · 2016 to 2020
$10.2M
The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and MetastaseU54CA143970 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2009 to 2014
$9.3M
Patient-specific predictive modeling that integrates advanced cancer imagingR01CA164371 · NCI · UNIVERSITY OF WASHINGTON · PI KINAHAN, PAUL E., SWANSON, KRISTIN R · 2011 to 2015
$4.5M
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in GlioblastomaU01CA220378 · NCI · MAYO CLINIC ARIZONA · PI HU, LELAND, SWANSON, KRISTIN R · 2017 to 2021
$4.3M
Novel Tools for Evaluation and Prediction of Radiotherapy Response in IndividualR01NS060752 · NINDS · UNIVERSITY OF WASHINGTON · PI SWANSON, KRISTIN R · 2009 to 2013
$1.6M
NCI NIH HHS P01 CA042045NCI NIH HHS R01 CA164371NCI NIH HHS U01 CA220378NCI NIH HHS U54 CA143970NCI NIH HHS U54 CA193489NCI NIH HHS U54 CA210180NINDS NIH HHS R01 NS060752
6 · The paper itself

Abstract

Paracrine PDGF signaling is involved in many processes in the body, both normal and pathological, including embryonic development, angiogenesis, and wound healing as well as liver fibrosis, atherosclerosis, and cancers. We explored this seemingly dual (normal and pathological) role of PDGF mathematically by modeling the release of PDGF in brain tissue and then varying the dynamics of this release. Resulting simulations show that by varying the dynamics of a PDGF source, our model predicts three possible outcomes for PDGF-driven cellular recruitment and lesion growth: (1) localized, short duration of growth, (2) localized, chronic growth, and (3) widespread chronic growth. Further, our model predicts that the type of response is much more sensitive to the duration of PDGF exposure than the maximum level of that exposure. This suggests that extended duration of paracrine PDGF signal during otherwise normal processes could potentially lead to lesions having a phenotype consistent with pathologic conditions.

Indexed as

Models, NeurologicalAnimalsBrainBrain NeoplasmsComputer SimulationHumansMathematical ConceptsOligodendrocyte Precursor CellsParacrine CommunicationPlatelet-Derived Growth FactorPlatelet-Derived Growth FactorGliosisOligodendroglial progenitorsPlatelet-derived growth factorScarring

Identifiers

PMID30796683
PMCPMC6494675
OpenAlexW2915417669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.